Author:
Schättler Heinz,Ledzewicz Urszula,Amini Behrooz
Funder
National Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Applied Mathematics,Agricultural and Biological Sciences (miscellaneous),Modelling and Simulation
Reference50 articles.
1. André N, Padovani L, Pasquier E (2011) Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy? Future Oncol 7(3):385–394
2. Benzekry S, Hahnfeldt P (2013) Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers. J Theor Biol 335:235–244
3. Benzekry S, André N, Benabdallah A, Ciccolini J, Faivre C, Hubert F, Barbolosi D (2012) Modeling the impact of anticancer agents on metastatic spreading. Math Model Nat Phenom 7(1):306–336. doi:
10.1051/mmnp/20127114
4. Bocci G, Nicolaou K, Kerbel RS (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62:6938–6943
5. Browder T, Butterfield CE, Kräling BM, Shi B, Marshall B, O’Reilly MS, Folkman J (2000) Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60:1878–1886
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献